Inhibition of the MUC1-C oncoprotein is synergistic with cytotoxic agents in the treatment of breast cancer cells

References

• Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009; 9:874 - 85; http://dx.doi.org/10.1038/nrc2761; PMID: 19935676
   PubMed Web of Science ®Google Scholar
• Kufe DW. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene 2012; In press http://dx.doi.org/10.1038/onc.2012.158; PMID: 22580612
   PubMed Web of Science ®Google Scholar
• Ramasamy S, Duraisamy S, Barbashov S, Kawano T, Kharbanda S, Kufe D. The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol Cell 2007; 27:992 - 1004; http://dx.doi.org/10.1016/j.molcel.2007.07.031; PMID: 17889671
   PubMed Web of Science ®Google Scholar
• Raina D, Kharbanda S, Kufe D. The MUC1 oncoprotein activates the anti-apoptotic PI3K/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts. J Biol Chem 2004; 279:20607 - 12; http://dx.doi.org/10.1074/jbc.M310538200; PMID: 14999001
   PubMed Web of Science ®Google Scholar
• Wei X, Xu H, Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 2005; 7:167 - 78; http://dx.doi.org/10.1016/j.ccr.2005.01.008; PMID: 15710329
   PubMed Web of Science ®Google Scholar
• Ahmad R, Raina D, Joshi MD, Kawano T, Ren J, Kharbanda S, et al. MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor. Cancer Res 2009; 69:7013 - 21; http://dx.doi.org/10.1158/0008-5472.CAN-09-0523; PMID: 19706766
   PubMed Web of Science ®Google Scholar
• Li Y, Liu D, Chen D, Kharbanda S, Kufe D. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene 2003; 22:6107 - 10; http://dx.doi.org/10.1038/sj.onc.1206732; PMID: 12955090
   PubMed Web of Science ®Google Scholar
• Leng Y, Cao C, Ren J, Huang L, Chen D, Ito M, et al. Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. J Biol Chem 2007; 282:19321 - 30; http://dx.doi.org/10.1074/jbc.M703222200; PMID: 17500061
   PubMed Web of Science ®Google Scholar
• Wei X, Xu H, Kufe D. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene. Cancer Res 2007; 67:1853 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-06-3063; PMID: 17308127
   PubMed Web of Science ®Google Scholar
• Ren J, Agata N, Chen D, Li Y, Yu W-H, Huang L, et al. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell 2004; 5:163 - 75; http://dx.doi.org/10.1016/S1535-6108(04)00020-0; PMID: 14998492
   PubMed Web of Science ®Google Scholar
• Ren J, Bharti A, Raina D, Chen W, Ahmad R, Kufe D. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90. Oncogene 2006; 25:20 - 31; PMID: 16158055
   PubMed Web of Science ®Google Scholar
• Raina D, Ahmad R, Joshi MD, Yin L, Wu Z, Kawano T, et al. Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells. Cancer Res 2009; 69:5133 - 41; http://dx.doi.org/10.1158/0008-5472.CAN-09-0854; PMID: 19491255
   PubMed Web of Science ®Google Scholar
• Zhou J, Rajabi H, Kufe D. MUC1-C oncoprotein is a target for small molecule inhibitors. Mol Pharm 2011; 79:886 - 93; http://dx.doi.org/10.1124/mol.110.070797
   PubMed Web of Science ®Google Scholar
• Raina D, Ahmad R, Rajabi H, Panchamoorthy G, Kharbanda S, Kufe D. Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells. Int J Oncol 2012; 40:1643 - 9; PMID: 22200620
   PubMed Web of Science ®Google Scholar
• Raina D, Kosugi M, Ahmad R, Panchamoorthy G, Rajabi H, Alam M, et al. Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells. Mol Cancer Ther 2011; 10:806 - 16; http://dx.doi.org/10.1158/1535-7163.MCT-10-1050; PMID: 21421804
   PubMed Web of Science ®Google Scholar
• Joshi MD, Ahmad R, Yin L, Raina D, Rajabi H, Bubley G, et al. MUC1 oncoprotein is a druggable target in human prostate cancer cells. Mol Cancer Ther 2009; 8:3056 - 65; http://dx.doi.org/10.1158/1535-7163.MCT-09-0646; PMID: 19887552
   PubMed Web of Science ®Google Scholar
• Raina D, Ahmad R, Kumar S, Ren J, Yoshida K, Kharbanda S, et al. MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. EMBO J 2006; 25:3774 - 83; http://dx.doi.org/10.1038/sj.emboj.7601263; PMID: 16888623
   PubMed Web of Science ®Google Scholar
• Amm HM, Zhou T, Steg AD, Kuo H, Li Y, Buchsbaum DJ. Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells. Mol Cancer Res 2011; 9:403 - 17; http://dx.doi.org/10.1158/1541-7786.MCR-10-0133; PMID: 21357440
   PubMed Web of Science ®Google Scholar
• Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22:27 - 55; http://dx.doi.org/10.1016/0065-2571(84)90007-4; PMID: 6382953
   PubMedGoogle Scholar
• Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010; 70:440 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-09-1947; PMID: 20068163
   PubMed Web of Science ®Google Scholar
• Yin L, Li Y, Ren J, Kuwahara H, Kufe D. Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. J Biol Chem 2003; 278:35458 - 64; http://dx.doi.org/10.1074/jbc.M301987200; PMID: 12826677
   PubMed Web of Science ®Google Scholar
• Yin L, Kharbanda S, Kufe D. Mucin 1 oncoprotein blocks hypoxia-inducible factor 1alpha activation in a survival response to hypoxia. J Biol Chem 2007; 282:257 - 66; http://dx.doi.org/10.1074/jbc.M610156200; PMID: 17102128
   PubMed Web of Science ®Google Scholar
• Yin L, Kharbanda S, Kufe D. MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation. Int J Oncol 2009; 34:1691 - 9; PMID: 19424588
   PubMed Web of Science ®Google Scholar
• Huang L, Chen D, Liu D, Yin L, Kharbanda S, Kufe D. MUC1 oncoprotein blocks GSK3β-mediated phosphorylation and degradation of β-catenin. Cancer Res 2005; 65:10413 - 22; http://dx.doi.org/10.1158/0008-5472.CAN-05-2474; PMID: 16288032
   PubMed Web of Science ®Google Scholar
• Rajabi H, Ahmad R, Jin C, Kosugi M, Alam M, Joshi M, et al. MUC1-C oncoprotein induces TCF7L2 activation and promotes cyclin D1 expression in human breast cancer cells. J Biol Chem 2012; 287:10703 - 13; http://dx.doi.org/10.1074/jbc.M111.323311; PMID: 22318732
   PubMed Web of Science ®Google Scholar
• Ahmad R, Alam M, Rajabi H, Kufe D. The MUC1-C oncoprotein binds to the BH3 domain of the pro-apoptotic BAX protein and blocks BAX function. J Biol Chem 2012; 287:20866 - 75; http://dx.doi.org/10.1074/jbc.M112.357293; PMID: 22544745
   PubMed Web of Science ®Google Scholar